BOSTON, MA — DPS Group, a global engineering, procurement, construction management and validation firm serving high-tech process industries, announces that Jim Grunwald has been promoted to Senior Vice President for U.S. Business Development. Based in the DPS Boston office, Grunwald will be responsible for sales and marketing of DPS Group’s services throughout U.S. markets and the company’s U.S. business units, including architectural and engineering design; commissioning, qualification and validation (CQV); technical services operation; construction management; and strategic consulting.
“Since joining DPS, Jim has played a key role in expanding Boston’s project portfolio, working closely with senior management to lead Boston project operations during a time of steady growth,” said Frank Keogh, Chief Executive Officer of DPS Group. “Jim has made outstanding contributions toward advancing DPS’ strategic initiatives, and we are confident in his ability to competitively position the firm and help grow the DPS business in the U.S. life sciences market.”
Grunwald brings more than 30 years of experience in the AEC industry to his new position. He joined DPS Group in 2015 and previously served as Vice President of Strategic Development for Boston’s project operations. In this role, he successfully led teams and delivered strategic capital projects for leading biotech/pharmaceutical and advanced technology clients. Grunwald supports all of DPS’ internal and external client relationships with guidance in the areas of planning, risk assessment, site selection, estimating, CQV and operational readiness.
He also has special expertise in strategic planning, real estate development and risk assessments associated with capital projects and product development in the regulated industry and advanced technology sectors. Additionally, Grunwald fulfills the role of project sponsor for many of DPS’ strategic project initiatives, providing senior management oversight and guidance to project teams on behalf of clients including Moderna, Sanofi, AbbVie, Acorda, Brammer Bio and Waters Corporation.
Grunwald is an active member of ISPE Boston, having previously served as President of the chapter’s board of directors and helping to start the ISPE Boston Chapter Scholarship Fund. He is also a founding member of the I2SL New England Chapter.